RN7SL475P

Across TCGA pan-cancer cohorts, RN7SL475P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RN7SL475P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RN7SL475P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL475P expression acts as an unfavorable survival marker.

KIRC, UCS, and UCEC are the cancer types where RN7SL475P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	II,III,IV	0.338	0.706	<.001	96	view →
UCS	OS	Tertile	All	0.125	0.710	<.001	90	view →
UCEC	DFS	Tertile	II,III,IV	0.120	0.523	.006	48	view →
STAD	OS	Tertile	All	0.459	0.755	.004	45	view →
READ	OS	Tertile	II,III,IV	0.187	0.644	.023	36	view →
PCPG	DFS	Tertile	All	0.112	0.769	.021	18	view →
LGG	DFS	Tertile	All	0.694	0.849	.002	15	view →
SKCM	DFS	Tertile	III,IV	0.037	0.597	<.001	9	view →
GBM	OS	Tertile	All	0.265	0.437	.027	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RN7SL475P–KIRC (OS)

Open the KIRC breakdown →